Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studiesI. Aayishamma, E Haripriya, Gurubasavaraja Swamy Purawarga Matada et al.|European Journal of Medicinal Chemistry|2024Cited by 32
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief reviewPrasad Sanjay Dhiwar, Ganesh S. Andhale, Lalmohan Maji et al.|Journal of Biomolecular Structure and Dynamics|2023Cited by 28
An updated literature on BRAF inhibitors (2018–2023)Lalmohan Maji, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli et al.|Molecular Diversity|2023Cited by 24
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationshipNimmagadda Venkata Satya Sai Aishwarya, Abhishek Ghara, Gurubasavaraja Swamy Purawarga Matada et al.|Journal of Molecular Structure|2024Cited by 15
BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline DerivativesArghya Paik, Hemalatha Kamurthy, Gurubasavaraja Swamy Purawarga Matada et al.|European Journal of Medicinal Chemistry|2025Cited by 8